Opportunities for New Testing to Screen Blood Donations

Slide1

The blood screen testing market is apparently plateauing, with risks of decline over the next few years, as more patents expire.

Additionally, there have been structural industry changes that could accelerate this, particularly the acquisition of Gen-Probe by Hologic. The acquisition also affects Novartis in the nucleic acid testing part of the business.

However, there are many untapped markets and many regions where blood donations themselves should be higher to have modern public health.

The report below shows that the future market for blood screening should be very robust for those firms that pursue the right regions with the right products.

Blood Screening Opportunities

© 2013 Winton Gibbons

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s